A detailed history of Bank Of America Corp transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 95,489 shares of STRO stock, worth $389,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,489
Previous 57,397 66.37%
Holding current value
$389,595
Previous $324,000 13.89%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $111,228 - $203,030
38,092 Added 66.37%
95,489 $279,000
Q1 2024

May 15, 2024

SELL
$3.27 - $5.65 $175,576 - $303,365
-53,693 Reduced 48.33%
57,397 $324,000
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $88,813 - $194,788
42,905 Added 62.92%
111,090 $476,000
Q2 2023

Aug 14, 2023

SELL
$4.25 - $5.88 $1.05 Million - $1.45 Million
-247,112 Reduced 78.37%
68,185 $317,000
Q1 2023

May 12, 2023

BUY
$4.48 - $8.45 $760,287 - $1.43 Million
169,707 Added 116.57%
315,297 $1.46 Million
Q4 2022

Feb 10, 2023

BUY
$5.41 - $8.08 $551,159 - $823,174
101,878 Added 233.07%
145,590 $1.18 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $116,567 - $160,309
22,547 Added 106.53%
43,712 $242,000
Q2 2022

Aug 12, 2022

SELL
$3.41 - $8.95 $839,112 - $2.2 Million
-246,074 Reduced 92.08%
21,165 $110,000
Q1 2022

May 16, 2022

BUY
$7.78 - $15.31 $1.17 Million - $2.31 Million
150,809 Added 129.53%
267,239 $2.2 Million
Q4 2021

Feb 08, 2022

BUY
$14.25 - $23.53 $1.14 Million - $1.89 Million
80,217 Added 221.51%
116,430 $1.73 Million
Q3 2021

Nov 15, 2021

BUY
$16.88 - $22.38 $21,471 - $28,467
1,272 Added 3.64%
36,213 $684,000
Q2 2021

Sep 13, 2021

BUY
$18.03 - $23.82 $629,986 - $832,294
34,941 New
34,941 $649,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $213M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.